摘要 |
This invention relates to the chemoprevention of prostate cancer and, more particularly, provides the use of a chemopreventive agent, e.g. toremifene and analogs or metabolites thereof, in the manufacture of a pharmaceutical preparation to prevent recurrence of, suppress or inhibit prostate carcinogenesis. The present invention provides a safe and effective method for suppressing or inhibiting latent prostate cancer and is particularly useful for treating subjects having an elevated risk of developing prostate cancer, for example, those having benign prostatic hyperplasia, prostate intraepithelial neoplasia (PIN), or an abnormally high level of circulating prostate specific antibody (PSA), or who have a family history of prostate cancer. |